A Phase 1, Open-label Study In Healthy Subjects To Investigate the Pharmacokinetics Of Pf-06412562 Following Single Oral Administration Of Modified Release Formulation In Fasted And Fed States

Trial Profile

A Phase 1, Open-label Study In Healthy Subjects To Investigate the Pharmacokinetics Of Pf-06412562 Following Single Oral Administration Of Modified Release Formulation In Fasted And Fed States

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Nov 2015

At a glance

  • Drugs PF 6412562 (Primary)
  • Indications Cognition disorders
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Nov 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
    • 06 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 08 Sep 2014 Protocol has been amended to change in primary outcomes that resulted in change in the trial focus from pharmacokinetics and adverse reaction to only pharmacokinetics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top